Cargando…
Lipopolysaccharide-binding protein (LBP) reverses the amyloid state of fibrin seen in plasma of type 2 diabetics with cardiovascular co-morbidities
Type 2 diabetes (T2D) has many cardiovascular complications, including a thrombotic propensity. Many such chronic, inflammatory diseases are accompanied (and may be exacerbated, and possibly even largely caused) by amyloid fibril formation. Recognising that there are few strong genetic associations...
Autores principales: | Pretorius, Etheresia, Mbotwe, Sthembile, Kell, Douglas B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5574907/ https://www.ncbi.nlm.nih.gov/pubmed/28851981 http://dx.doi.org/10.1038/s41598-017-09860-4 |
Ejemplares similares
-
Lipopolysaccharide-binding protein (LBP) can reverse the amyloid state of fibrin seen or induced in Parkinson's disease
por: Pretorius, Etheresia, et al.
Publicado: (2018) -
Acute induction of anomalous and amyloidogenic blood clotting by molecular amplification of highly substoichiometric levels of bacterial lipopolysaccharide
por: Pretorius, Etheresia, et al.
Publicado: (2016) -
The Potential of LPS-Binding Protein to Reverse Amyloid Formation in Plasma Fibrin of Individuals With Alzheimer-Type Dementia
por: Pretorius, Etheresia, et al.
Publicado: (2018) -
Both lipopolysaccharide and lipoteichoic acids potently induce anomalous fibrin amyloid formation: assessment with novel Amytracker™ stains(†)
por: Pretorius, Etheresia, et al.
Publicado: (2018) -
The effect of physiological levels of South African puff adder (Bitis arietans) snake venom on blood cells: an in vitro model
por: Strydom, Morné A., et al.
Publicado: (2016)